25
Mar 2026
Sleep apps help you track sleep, but can they also increase anxiety?
Sleep apps offer data-driven insights for better rest, but may increase anxiety in some users. Study reveals varied effects based on demographics and insomnia.
Stay Informed!
25
Mar 2026
An Arm and a Leg: Steep health care costs steer Americans to tough decisions
Health insurance is out of reach for millions of Americans this year. Many are making difficult decisions about how to pay for coverage amid the loss of Affordable Care Act subsidies and nosebleed-high premiums.
25
Mar 2026
New skin atlas maps over one million cells across the human body
Mount Sinai researchers have published the first organ-wide human skin spatial atlas from across the body.
25
Mar 2026
Can collagen supplements really improve your skin?
Investigating collagen peptides, this review explores their role in skin aging, assessing clinical evidence and the mechanisms behind their potential benefits.
25
Mar 2026
Eating more dairy and calcium may lower metabolic syndrome odds
Research links higher dietary calcium and dairy consumption to reduced odds of metabolic syndrome, highlighting potential dietary interventions for health.
25
Mar 2026
Systematic review identifies stress-induced biological triggers in oncology
Stress is a constant companion in the oncologist's office. It appears at the time of diagnosis, increases with each stage of treatment, and often does not resolve even after therapy formally ends. It accompanies therapeutic decisions, waiting for test results, fear of recurrence, and changes in daily functioning. Studies show that chronic stress can trigger biological processes that promote disease progression and weaken the body's defenses.
25
Mar 2026
iXCells Biotechnologies joins international collaboration to evaluate chemotherapeutic toxicity in human organoids
iXCells Biotechnologies ("iXCells"), a leading provider of human cell-based solutions and custom iPSC services, today announced it has entered an international collaboration with Rosebud Biosciences ("Rosebud"), Kantify, and Incite to evaluate off-target chemotherapeutic toxicities in patient-specific organoids.
25
Mar 2026
Optibrium introduces graphical interface for QuanSA to enhance ligand-based affinity predictions
Optibrium, a leading developer of software and AI solutions for molecular design, today announced a new QuanSA™ plugin for PyMOL, providing an intuitive Graphical User Interface (GUI) for its ligand-based binding affinity prediction method, part of the Company's BioPharmics 3D molecular modelling platform.
25
Mar 2026
Primerdesign partners with Origin Sciences to create novel rectal mucosal extraction workflow
Primerdesign (part of the Novacyt Group), a company focused on the design, manufacture, validation and supply of nucleic acid extraction and real-time PCR kits, and Origin Sciences (Origin), a company pioneering the detection and diagnosis of gastrointestinal (GI) disease through an unprecedented focus on a unique biospecimen: rectal mucus; today announced a strategic partnership to create a new protocol that optimizes DNA extraction from novel rectal mucosal samples.
25
Mar 2026
Navigating the moral landscape of pediatric AI surgery
Technological innovation has always driven surgical progress, and AI now represents the next transformative wave. Machine learning models are now being developed to predict surgical risks, assist in diagnosing rare congenital disorders, analyze imaging data, and anticipate postoperative complications. Risk prediction tools have already shifted from traditional statistical methods to more complex machine learning approaches, improving their ability to account for nonlinear interactions.
